Uceris Tablet, Extended Release
Product Images NDC 68012-309

5 FDA label images from Santarus Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Uceris (NDC 68012-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Santarus Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

2nd Table

2nd Table
Partial text panel listing symptoms including fever, pain, aches, chills, feeling tired, and nausea and vomiting. The text appears to be part of a medication guide or warning section related to Uceris (budesonide) extended-release oral tablets.*
FDA Label Image

Image 01

Image 01
Label for Uceris 9 mg extended release tablets, containing budesonide for oral use. The label indicates the product is distributed by Salix Pharmaceuticals and manufactured by Cosmo S.p.A. The package contains 30 tablets, with instructions to swallow whole without chewing or breaking. A barcode and storage guidelines are also shown.*
FDA Label Image

Table 3

Table 3
A text panel listing potential adverse effects or symptoms, including headache, nausea, decreased blood cortisol levels, stomach-area pain, tiredness, stomach or intestinal gas, bloating, acne, urinary tract infection, joint pain, and constipation.*
FDA Label Image

Table

Table
A portion of a drug information panel listing side effects including tiredness, weakness, nausea, vomiting, and low blood pressure. The text is in bullet point format without additional context or headings.*
FDA Label Image

Uceris-1.jpg (Uceris 1)

Uceris-1.jpg (Uceris 1)
Chemical structure of budesonide, the active ingredient in Uceris 9 mg extended release oral tablets by Santarus Inc. The structure shows the steroid framework with hydroxyl, carbonyl, and other functional groups characteristic of budesonide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.